Skip to content

Commit

Permalink
Add CNN leak, not sure about the merits but it fits into News for sure
Browse files Browse the repository at this point in the history
  • Loading branch information
ljl-covid committed Dec 1, 2020
1 parent 1b7c4a7 commit 09473a2
Showing 1 changed file with 1 addition and 0 deletions.
1 change: 1 addition & 0 deletions README.md
Expand Up @@ -397,6 +397,7 @@ There is mixed advice on the use of masks by the general public, and the advice
* [Oxford University](https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine) and [AstraZeneca](https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/azd1222hlr.html) both issue press releases on interim efficacy assessment of their ChAdOx1 nCoV-2019 vaccine, showing overall 70% efficacy but divided into 62% for a group that received two full doses, and 90% for a group receiving a half dose followed by a full-dose booster, and Derek Lowe discusses these results and the methodological differences compared to Pfizer and Moderna in [Oxford/AZ Vaccine Efficacy Data](https://blogs.sciencemag.org/pipeline/archives/2020/11/23/oxford-az-vaccine-efficacy-data)
* [Second interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose](https://sputnikvaccine.com/newsroom/pressreleases/second-interim-analysis-of-clinical-trial-data-showed-a-91-4-efficacy-for-the-sputnik-v-vaccine-on-d/), as announced by Gamaleya in a press release, where it was also specified that no significant adverse reactions have occurred; the international price for this vaccine was stated as being below $10
* [Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization](https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-primary-efficacy-analysis-phase-3-cove-study) in a press release where efficacy is put at 94.1%, with 100% efficacy against "severe" cases, after 196 COVID cases have developed within the trial participants, and after more than two months of follow-up
* [The Wuhan files — Leaked documents reveal China's mishandling of the early stages of Covid-19](https://edition.cnn.com/2020/11/30/asia/wuhan-china-covid-intl/index.html) is a CNN release of excerpts of private documents from the Chinese government supposedly showing cover-ups of facts about the epidemic, including a 20-fold increase of what was thought to be influenza in Hubei during December 2019


## API and feeds
Expand Down

0 comments on commit 09473a2

Please sign in to comment.